Related Experiment Video
Updated: Jun 4, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction
Abstract:
The Mdm2/p53 pathway is compromised in more than 50% of all human cancers, therefore it is an intensive area of research to understand the upstream regulatory pathways governing Mdm2/p53 activity. Mdm2 is frequently overexpressed in human cancers while the molecular mechanisms underlying the timely destruction of Mdm2 remain unclear. We recently reported that Casein Kinase I phosphorylates Mdm2 at multiple sites to trigger Mdm2 interaction with, and subsequent ubiquitination and destruction by the SCF(β-TRCP) E3 ubiquitin ligase. We also demonstrated that the E3 ligase activity-deficient Mdm2 was still unstable in the G1 phase and could be efficiently degraded by SCF(β-TRCP). Thus our finding expands the current knowledge on how Mdm2 is tightly regulated by both self- and SCF(β-TRCP)-dependent ubiquitination to control p53 activity in response to stress. It further indicates that loss of β-TRCP or Casein Kinase I function contributes to elevated Mdm2 expression that is frequently found in various types of tumors.
Insights
Casein Kinase I targets Mdm2 for destruction by the SCF(β-TRCP) E3 ligase, controlling the Mdm2/p53 pathway crucial for cancer. This mechanism explains Mdm2 overexpression in tumors when Casein Kinase I or β-TRCP function is lost.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Regulation
Background:
- The Mdm2/p53 pathway is critical in cancer, with Mdm2 frequently overexpressed.
- Mechanisms regulating Mdm2 destruction are not fully understood.
- Mdm2 regulates the tumor suppressor p53.
Purpose of the Study:
- To elucidate the upstream regulatory pathways controlling Mdm2/p53 activity.
- To identify mechanisms responsible for Mdm2 degradation.
- To understand Mdm2 regulation in cancer.
Main Methods:
- Phosphorylation site mapping of Mdm2 by Casein Kinase I.
- Analysis of Mdm2 interaction with SCF(β-TRCP) E3 ubiquitin ligase.
- Assessment of Mdm2 ubiquitination and degradation.
- Evaluation of Mdm2 stability in G1 phase.
Main Results:
- Casein Kinase I phosphorylates Mdm2 at multiple sites.
- Phosphorylation triggers Mdm2 interaction with SCF(β-TRCP) for ubiquitination and destruction.
- E3 ligase-deficient Mdm2 is degraded by SCF(β-TRCP) in G1 phase.
- Mdm2 is regulated by self- and SCF(β-TRCP)-dependent ubiquitination.
Conclusions:
- Mdm2 degradation is regulated by Casein Kinase I and SCF(β-TRCP).
- This pathway tightly controls p53 activity in response to stress.
- Loss of β-TRCP or Casein Kinase I function contributes to elevated Mdm2 in tumors.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nuclear Export of mRNA
Anaphase Promoting Complex

